Free Trial

LENZ Therapeutics (LENZ) Institutional Ownership

LENZ Therapeutics logo
$23.82 +0.76 (+3.30%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$23.94 +0.13 (+0.52%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)

Current
Institutional Ownership
Percentage
54.32%
Number of
Institutional Buyers
(last 12 months)
54
Total
Institutional Inflows
(last 12 months)
$164.50M
Number of
Institutional Sellers
(last 12 months)
16
Total
Institutional Outflows
(last 12 months)
$13.52M
Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/14/2025 Harbor Capital Advisors Inc.48,616$1.25M0.1%+10.5%0.177%
4/8/2025 Rhumbline Advisers17,967$462K0.0%-4.2%0.065%
4/7/2025 GAMMA Investing LLC5,836$150K0.0%+5,254.1%0.021%
3/24/2025Wellington Management Group LLP28,216$815K0.0%+14.6%0.103%
3/18/2025California State Teachers Retirement System9,200$266K0.0%+911.0%0.033%
2/18/2025Delta Investment Management LLC19,241$555K0.1%N/A0.070%
2/17/2025Vivaldi Capital Management LP56,252$1.62M0.2%-4.3%0.205%
2/17/2025Two Sigma Investments LP17,079$493K0.0%-33.0%0.062%
2/17/2025Rafferty Asset Management LLC17,716$511K0.0%N/A0.064%
2/17/2025Point72 Asset Management L.P.783,921$22.63M0.0%-9.4%2.851%
2/17/2025Paradigm Biocapital Advisors LP770,455$22.24M0.8%N/A2.802%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,914$229K0.0%+14.5%0.029%
2/17/2025Granahan Investment Management LLC51,842$1.50M0.1%N/A0.189%
2/17/2025Deutsche Bank AG9,723$281K0.0%+81.6%0.035%
2/17/2025D. E. Shaw & Co. Inc.7,447$215K0.0%N/A0.027%
2/17/2025Bank of America Corp DE38,246$1.10M0.0%+92.7%0.139%
2/17/2025BNP Paribas Financial Markets1,789$52K0.0%-32.4%0.007%
2/17/2025Ameriprise Financial Inc.48,088$1.39M0.0%-26.0%0.175%
2/17/2025Alyeska Investment Group L.P.142,113$4.10M0.0%+16.4%0.517%
2/14/2025Jane Street Group LLC7,938$229K0.0%-34.0%0.029%
2/14/2025Samsara BioCapital LLC986,981$28.49M3.9%-18.3%3.589%
2/14/2025Northern Trust Corp139,288$4.02M0.0%+7.4%0.507%
2/14/2025The Manufacturers Life Insurance Company 67,891$1.96M0.0%+116.8%0.247%
2/14/2025Boothbay Fund Management LLC39,746$1.15M0.0%-26.9%0.145%
2/14/2025Virtus ETF Advisers LLC2,309$67K0.0%N/A0.008%
2/14/2025Price T Rowe Associates Inc. MD822,957$23.76M0.0%+83.4%2.993%
2/14/2025Rock Springs Capital Management LP29,305$846K0.0%N/A0.107%
2/14/2025Tower Research Capital LLC TRC 1,860$54K0.0%+162.3%0.007%
2/13/2025Barclays PLC30,057$867K0.0%+82.6%0.109%
2/13/2025Raymond James Financial Inc.8,485$245K0.0%N/A0.031%
2/13/2025Renaissance Technologies LLC25,366$732K0.0%-48.5%0.092%
2/13/2025Legal & General Group Plc8,742$252K0.0%+703.5%0.032%
2/13/2025Wells Fargo & Company MN7,504$217K0.0%+27.3%0.027%
2/12/2025Geode Capital Management LLC334,026$9.65M0.0%-1.2%1.215%
2/12/2025Alliancebernstein L.P.7,586$219K0.0%-18.8%0.028%
2/12/2025Wellington Management Group LLP28,216$815K0.0%+14.6%0.103%
2/12/2025JPMorgan Chase & Co.8,342$241K0.0%+46.4%0.030%
2/11/2025Corebridge Financial Inc.6,245$180K0.0%-7.0%0.023%
2/11/2025Vanguard Group Inc.1,178,447$34.02M0.0%+5.3%4.285%
2/11/2025KLP Kapitalforvaltning AS1,600$46K0.0%N/A0.006%
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
2/11/2025American Century Companies Inc.32,506$938K0.0%+36.2%0.118%
2/10/2025Swiss National Bank18,900$546K0.0%N/A0.069%
2/7/2025BML Capital Management LLC9,271$268K0.2%-84.5%0.034%
2/6/2025Raymond James Financial Inc.8,485$245K0.0%N/A0.031%
2/6/2025Charles Schwab Investment Management Inc.127,196$3.67M0.0%+3.1%0.463%
2/4/2025Bank of New York Mellon Corp29,214$843K0.0%-1.4%0.106%
1/30/2025 Rhumbline Advisers18,754$541K0.0%+6.2%0.068%
1/27/2025Mirae Asset Global Investments Co. Ltd.916$29K0.0%N/A0.003%
1/24/2025China Universal Asset Management Co. Ltd.5,831$168K0.0%N/A0.021%
1/17/2025 SG Americas Securities LLC5,458$158K0.0%+20.7%0.020%
1/17/2025Kelleher Financial Advisors17,023$491K0.2%-18.1%0.062%
1/10/2025 Harbor Capital Advisors Inc.43,989$1.27M0.1%N/A0.160%
11/19/2024Barclays PLC16,463$391K0.0%+273.1%0.060%
11/16/2024Geode Capital Management LLC338,024$8.03M0.0%-6.1%1.229%
11/15/2024Barclays PLC16,463$391K0.0%+273.1%0.060%
11/15/2024Jane Street Group LLC12,027$286K0.0%N/A0.044%
11/15/2024Wellington Management Group LLP24,621$585K0.0%N/A0.090%
11/15/2024State Street Corp289,154$6.87M0.0%+18.7%1.051%
11/15/2024Parkman Healthcare Partners LLC139,357$3.31M0.4%N/A0.507%
11/14/2024BBR Partners LLC40,000$950K0.1%+100.0%0.145%
11/14/2024MetLife Investment Management LLC7,672$182K0.0%N/A0.028%
11/13/2024BNP Paribas Financial Markets2,648$63K0.0%-83.9%0.010%
11/13/2024The Manufacturers Life Insurance Company31,309$743K0.0%N/A0.114%
11/12/2024Charles Schwab Investment Management Inc.123,371$2.93M0.0%+197.5%0.449%
11/5/2024BML Capital Management LLC60,000$1.42M0.8%-6.1%0.218%
11/5/2024GSA Capital Partners LLP10,357$246K0.0%N/A0.038%
10/3/2024 SG Americas Securities LLC4,523$107K0.0%N/A0.124%
8/15/2024Deerfield Management Company L.P. Series C17,353$300K0.0%N/A0.476%
8/14/2024Squarepoint Ops LLC10,477$181K0.0%N/A0.287%
8/14/2024Marshall Wace LLP22,554$390K0.0%N/A0.618%
8/9/2024Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649%
8/9/2024Dimensional Fund Advisors LP37,190$644K0.0%+58.0%1.019%
8/5/2024BBR Partners LLC20,000$346K0.0%N/A0.548%
8/1/2024 Rhumbline Advisers16,812$291K0.0%+265.6%0.461%
7/26/2024Bank of New York Mellon Corp39,737$687K0.0%+255.4%1.089%
7/16/2024 Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277%
5/17/2024RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488%
5/17/2024Ikarian Capital LLC85,000$1.90M0.2%N/A2.329%
5/16/2024Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019%
5/14/2024American International Group Inc.1,973$44K0.0%N/A0.054%
5/10/2024Vanguard Group Inc.206,952$4.62M0.0%N/A5.670%
5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161%
5/2/2024Jennison Associates LLC134,740$3.01M0.0%N/A3.692%
5/1/2024BNP Paribas Financial Markets16,221$362K0.0%N/A0.444%
4/25/2024BML Capital Management LLC63,916$1.43M0.9%N/A1.751%
(Data available from 1/1/2016 forward)

LENZ Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LENZ shares?

During the previous two years, 64 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Vanguard Group Inc. ($34.02M), Samsara BioCapital LLC ($28.49M), Price T Rowe Associates Inc. MD ($23.76M), Point72 Asset Management L.P. ($22.63M), Paradigm Biocapital Advisors LP ($22.24M), and Geode Capital Management LLC ($9.65M).Learn more on LENZ's institutional investors.

What percentage of LENZ Therapeutics stock is owned by institutional investors?

54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings.

Which institutional investors have been buying LENZ Therapeutics stock?

Of the 54 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Paradigm Biocapital Advisors LP ($770.46K), Price T Rowe Associates Inc. MD ($374.33K), Vanguard Group Inc. ($266.58K), Parkman Healthcare Partners LLC ($139.36K), Jennison Associates LLC ($134.74K), and Charles Schwab Investment Management Inc. ($85.73K).

How much institutional buying is happening at LENZ Therapeutics?

Institutional investors have bought a total of 6,930,798 shares in the last 24 months. This purchase volume represents approximately $164.50M in transactions.

Which LENZ Therapeutics major shareholders have been selling company stock?

Of the 16 institutional investors that sold LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Samsara BioCapital LLC ($221.49K), Point72 Asset Management L.P. ($81.02K), BML Capital Management LLC ($54.65K), Geode Capital Management LLC ($26.09K), Renaissance Technologies LLC ($23.90K), Ameriprise Financial Inc. ($16.85K), and BNP Paribas Financial Markets ($14.68K).

How much institutional selling is happening at LENZ Therapeutics?

Institutional investors have sold a total of 475,532 shares in the last 24 months. This volume of shares sold represents approximately $13.52M in transactions.



This page (NASDAQ:LENZ) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners